HealthEquity, Inc. (HQY): one to watch?
Interesting but unresolved — it beat earnings and raised guidance, yet sold off on growth-deceleration fears, so wait for the dust to settle.
Fell 11% in 1 trading day(s) — now $93.39
Why HQY dropped
HealthEquity reported Q2 fiscal 2026 results that beat analyst estimates on both revenue and EPS and management raised full-year guidance, yet the stock still fell about 13-14% that day.
Fwd P/E 17.1Op margin 29.3%Rev growth 7.2%Debt/equity 48.1%Analyst upside 26.9%
How this scored 76/100
✅ Passes all 4 hard checks — profitable, cash-generative, and financially survivable.
Makes money
Net profit margin 17.3%
Generates cash
Free cash flow $370M
Not drowning in debt
Debt/equity 48.1% (limit 200%)
Can pay its bills
Current ratio 3.4 (needs 1+)
Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.
Profitability
Does it actually make money?
18/25
Operating margin
29.3%
9/9
Net profit margin
17.3%
7/8
Return on equity
11.1%
2/8
Growth
Is it getting bigger, or dying?
20/25
Revenue growth
7.2%
4/9
Earnings growth
34.4%
8/8
Expected profit change
97.5%
8/8
Value
Is it cheap right now?
15/25
Forward P/E
17.1
7/10
PEG ratio
1.5
5/8
Analyst target upside
26.9%
3/7
Balance sheet
Will it survive?
23/25
Debt / equity
48.1%
8/10
Current ratio
3.4
8/8
Free cash flow
$370M
7/7
🔒 Read the full AI analysis
Create a free account to unlock the bull case and the risks for HQY — plus today's other picks.
Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-08-28. Research only — not financial advice.